Semaglutide has been associated with an increased risk of gallbladder-related conditions, such as cholelithiasis, particularly in the context of rapid weight loss. There have also been rare reports of pancreatitis with GLP-1 receptor agonists, making it important to monitor patients with a history of pancreatic disease. Furthermore, semaglutide carries a boxed warning (region-dependent) regarding the potential risk of medullary thyroid carcinoma (MTC), based on findings from animal studies
If your goal is to lose weight in a month, you can expect to lose around 3% to 4% of your starting weight, though individual results may vary
Constipation is a common semaglutide side effect, but if it isnt managed properly, it can lead to an intestinal blockage
instead, aim for a level of hunger that is not disruptive or oppressive and is manageable with your lifestyle
Scientific Evidence : The defense presents scientific studies that emphasize Ozempics benefits, particularly in weight management and blood sugar control
8: 392-406 (4) 2 GLP-1 () (5) 21118 Inui pediatrics and internal medicine clinic
